Rebuilding Reputations: COVID-19 Presents A Big Responsibility And Opportunity

The global COVID-19 crisis has presented a chance for industry to improve its reputation by highlighting the value of its R&D engines. Pharma executives and observers outline why they are optimistic about a chance to regain public trust.